Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
NCT ID: NCT06096324
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
500 participants
INTERVENTIONAL
2023-09-19
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
NCT05412433
Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing
NCT02248558
Resilient HIV Implementation Science With SGM Youths Using Evidence
NCT06350682
Empowerment Intervention for Young Women - Phase I
NCT00891358
Online HIV Prevention for Young Male Couples
NCT03284541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study team will collect efficacy data pertaining to the following outcomes at T1 (Aim 1): (i) the mean economic stability score of participants in each group in the past six months (=primary outcome); (ii), the proportion of participants in each group who report one or more vaginal or anal sex acts without using a condom in the past six months (=secondary outcome); and (iii) the proportion of participants in each group who report PrEP continuum progressive movement of one or more stages in the past six months (=secondary outcome). All outcomes data will be collected using participant surveys.
The study team will also collect data on other pre-specified measures from T1 to T3 to characterize the primary and secondary aims (Aim 1), to assess differences in the efficacy of the intervention by sex and peer support (Aim 2), and to explore potential mediating factors over time (Aim 3). These other pre-specified measures include: (i) the proportion of participants in each group who report one or more paid hours of work in the past six months; (ii) the mean financial distress score of participants in each group in the past six months; (iii) the mean total money spent on HIV prevention activities of participants in each group in the past six months; (iv) the mean economic self-efficacy score of participants in each group in the past six months; (v) the proportion of participants in each group who report one or more other sexual risk behaviors associated with HIV acquisition in the past six months; (vi) the proportion of participants in each group who report one or more other care-seeking behaviors associated with HIV prevention in the past six months; (vii) the mean condom self-efficacy score of participants in each group in the past six months; (viii) the mean PrEP self-efficacy score of participants in each group in the past six months; (ix) the mean grit score of participants in each group in the past six months; and (x) the mean industriousness score of participants in each group in the past six months. All other pre-specified data will also be collected using participant surveys.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
Participants will receive job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
Control
Job announcements only
Job announcements
Participants will receive job announcements only.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
Participants will receive job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
Job announcements
Participants will receive job announcements only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Economically-vulnerable in past 12 months
* Sexually active in past 12 months
* Living in Baltimore
* Has access to mobile phone with text messaging
Exclusion Criteria
* Older than 24 years
* Unwilling to provide consent for study participation
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Larissa Jennings Mayo-Wilson, PhD MHS
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Adriana Parker, MPH
Role: STUDY_DIRECTOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins University
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-1034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.